Rise in crashes caused by tourists driving on wrong side of road
The number of crashes caused by visitors to Scotland driving on the wrong side of the road has increased by 46% in a year.
Figures released by Transport Scotland showed there were 35 collisions caused by "inexperience of driving on the left" in 2023, up from 24 the previous year.
Campaigners have described the rise as "disappointing" and called for additional signage and prompts to be put in place as a reminder for tourists, particularly in rural areas.
Road Safety Scotland said there was no clear reason for the increased frequency of crashes.
One of the collisions recorded in the 2023 figures resulted in a death.
Signage is often placed at airports and other transport hubs and car hire facilities reminding drivers that vehicles in the UK drive on the left side of the road.
'Keep left' campaign targets tourists
Crash survivor in 'keep left' campaign
The vast majority of visitors to Scotland in 2023 came from mainland Europe and the United States – all of which are right-hand drive countries.
Sharon Anslow, founder of the Keep Left campaign, said more had to be done to educate drivers.
Mrs Anslow was injured when her car was pushed into a ditch during a head-on collision with a tourist while driving to work in Portree on the Isle of Skye in December 2018.
She had to be freed from the wreckage by fire crews and said she was forced to move house due to the trauma of driving on the same route during her work commute.
The other driver involved in the crash received a fixed penalty notice despite driving on the wrong side of the road for at least a mile before the crash.
Mrs Anslow told BBC Radio's Good Morning Scotland programme she had secured funding to put up 250 signs along the roads in Skye and Lochalsh to remind drivers where they should be.
But she said the onus should be on councils and road managers to keep other motorists safe.
"Raising awareness is fantastic and there are lots of resources online," she said.
"But it's not the answer. We should be providing, not just the tourists, but the locals across the whole of Scotland, with proper roads to drive on, with proper signage and directional arrows to keep everybody safe."
In 2022, Italian naval officer Alfredo Ciociola was convicted of killing five people, including his four-year-old son, in a crash on the A96 near Keith.
Two years earlier, Gerrit Reickmann, from Germany, caused the death of his girlfriend Melina Rose Päprer when he was involved in a head-on crash while driving on the wrong side of the road near Drumnadrochit in the Highlands.
Road Safety Scotland director, Michael McDonnell, said tourists often struggled in more rural areas, where there was little to no traffic to "prompt" them into driving on the correct side.
He also said tiredness could be a factor.
The organisation has worked with VisitScotland and car hire companies to educate tourists on where they should be driving.
They have provided vehicle rental companies with wristbands with the message "drive on the left" in nine different languages.
It is hoped that drivers would see them while they have their hands on the steering wheel.
Mr McDonnell said passengers also had a role to play in keeping the driver aware of where they should be on the road.
He said: "The difficulty we have in Scotland is that one of the attractions of the country is the remote, rural areas, the places people like to visit with its tremendous beauty spots.
"Quite often, people, when they go into these areas, they encounter less traffic and so, when there is a lot of traffic on the road you get hints as to where you should be.
"The same thing happens early in the morning or late at night when people set off, so you get this increase just when there isn't traffic on the road."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
How social media can 'trigger' eating disorders in young people
Social media can push vulnerable young people towards developing eating disorders by glorifying thinness and promoting fake, dangerous advice about diet and nutrition, experts warn. Young women and girls are much more likely to suffer from illnesses such as anorexia, bulimia and binge eating disorder, though rates among men have been increasing. Research has shown the percentage of people worldwide who have had some kind of eating disorder during their lives rose from 3.5 percent in 2000 to 7.8 percent in 2018, a timeframe that captures the rise of social media. For the professionals trying to help teenagers recover from these disorders, misinformation from influencers on platforms such as TikTok and Instagram is a huge problem. "We no longer treat an eating disorder without also addressing social media use," French dietitian and nutritionist Carole Copti told AFP. "It has become a trigger, definitely an accelerator and an obstacle to recovery," she added. The causes of eating disorders are complex, with psychological, genetic, environmental and social factors all having the potential to make someone more susceptible. Social media "is not the cause but the straw that may break the camel's back," said Nathalie Godart, a psychiatrist for children and adolescents at the Student Health Foundation of France. By promoting thinness, strictly controlled diets and relentless exercise, social media weakens already vulnerable people and "amplifies the threat" to their health, she told AFP. - 'Vicious cycle' - Just one recent example is the #skinnytok trend, a hashtag on TikTok full of dangerous and guilt-inducing advice encouraging people to drastically reduce how much food they eat. For Charlyne Buigues, a French nurse specialising in eating disorders, social media serves as a gateway to these problems, which are "normalised" online. She condemned videos showing young girls with anorexia exposing their malnourished bodies -- or others with bulimia demonstrating their "purges". "Taking laxatives or vomiting are presented as a perfectly legitimate way to lose weight, when actually they increase the risk of cardiac arrest," Buigues said. Eating disorders can damage the heart, cause infertility and other health problems, and have been linked to suicidal behaviour. Anorexia has the highest rate of death of any psychiatric disease, research has found. Eating disorders are also the second leading cause of premature death among 15- to 24-year-olds in France, according to the country's health insurance agency. Social media creates a "vicious cycle," Copti said. "People suffering from eating disorders often have low self-esteem. But by exposing their thinness from having anorexia on social media, they gain followers, views, likes... and this will perpetuate their problems and prolong their denial," she added. This can especially be the case when the content earns money. Buigues spoke of a young woman who regularly records herself throwing up live on TikTok and who had "explained that she was paid by the platform and uses that money to buy groceries". - 'Completely indoctrinated' - Social media also makes recovering from eating disorders "more difficult, more complicated and take longer", Copti said. This is partly because young people tend to believe the misleading or fake diet advice that proliferates online. Copti said consultations with her patients can feel like she is facing a trial. "I have to constantly justify myself and fight to make them understand that no, it is not possible to have a healthy diet eating only 1,000 calories -- that is half what they need -- or that no, it is not normal to skip meals," she said. "The patients are completely indoctrinated -- and my 45-minute weekly consultation is no match for spending hours every day on TikTok," she added. Godart warned about the rise of people posing as "pseudo-coaches", sharing incorrect, "absurd" and potentially illegal nutrition advice. "These influencers carry far more weight than institutions. We're constantly struggling to get simple messages across about nutrition," she said, pointing out that there are lifelines available for those in need. Buigues takes it upon herself to regularly report problematic content on Instagram, but said it "serves no purpose". "The content remains online and the accounts are rarely suspended -- it's very tiring," she said. The nurse has even advised her patients to delete their social media accounts, particularly TikTok. "It may seem radical but until young people are better informed, the app is too dangerous," she said. cra-dl/djt
Medscape
3 hours ago
- Medscape
Tumor Treating Fields Boost Pancreatic Cancer Survival
The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was associated with significantly improved overall survival in a phase 3 trial for patients with unresectable, locally advanced, pancreatic adenocarcinoma (LA-PAC). The PANOVA-3 trial 'establishes tumor treating fields with gemcitabine/nab-paclitaxel as a potential new standard treatment paradigm for unresectable, locally advanced pancreatic cancer,' reported Vincent J. Picozzi, MD, first author of the new research, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting. The new study, which was simultaneously published in the Journal of Clinical Oncology , is the first phase 3 trial to show an overall survival (OS) benefit for any treatment added to standard chemotherapy in this patient population, where the current 5-year OS rate is less than 8%, said Picozzi in his presentation. TTFields is a non-invasive therapy that delivers electricity to the tumor site via a wearable device and transducer arrays placed on the skin. The electric fields 'disrupt processes critical for cancer cell division and may do a variety of other things, such as trigger an enhanced anti-tumor response,' he explained. The therapy has already been approved in the United States and Europe for use in various cancers, including glioblastomas, metastatic pleural mesothelioma, and metastatic non-small cell lung cancer (NSCLC). Study Methods The open-label study, conducted across 20 countries and 196 sites, included 571 patients with unresectable, locally advanced, biopsy-confirmed, and previously untreated pancreatic adenocarcinoma. Participants had a life expectancy of at least 3 months and Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-2. The patients (median age 67 years, 47.6% male) were randomly assigned to receive only gemcitabine 1000 mg/m2 and nab-paclitaxel 125 mg/m2 by intravenous infusion once a day on days 1, 8, and 15 of a 28-day cycle (n = 286), or the same chemotherapy plus TTFields (n = 285). Patients wore the devices about 15 hours per day for about 28 weeks on average. Notably, almost 30% of the patients were non-White, almost 4% were ECOG PS 2, 'and perhaps most importantly, almost 30% had CA 19-9 levels greater than 1000, suggesting a high incidence of occult, unrecognized metastatic disease,' said Picozzi, a hematologist-oncologist and director of the Pancreaticobiliary Program at Virginia Mason Medical Center, Seattle, Washington. Follow-up visits were every 4 weeks, with chest, abdomen, and brain CT or MRI performed every 8 weeks to assess disease progression. Study Results After a median follow-up of about 13 months, the primary endpoint of OS was statistically improved in the TTFields arm compared with controls (16.2 vs 14.2 months, hazard ratio [HR] 0.82, P = .039), and the 1-year survival rate was similarly better (68.1% vs 60.2%; P = .029). There was no significant difference between groups in median progression-free survival (PFS), at 10.6 vs 9.3 months, respectively. However, the 1-year PFS rate was higher in the TTFields arm (43.9% vs 34.1%, P = .026). 'Perhaps somewhat surprisingly,' a post-hoc analysis showed a statistically significant benefit to TTFields in distant PFS, Picozzi said. Importantly, TTFields showed benefit in quality of life. 'In pain-free survival, another secondary endpoint — which really is freedom from progression of pain over time — we see a very distinct difference' (median 15.2 vs 9.1 months, 1-year pain-free survival rate 54.1% vs 45.1%), he reported. 'Pain is a common and debilitating morbidity in patients with advanced pancreatic adenocarcinoma and a predictor of survival. Thus, by mitigating cancer pain, TTFields may preserve the quality of life of patients with LA-PAC, further supporting TTFields' utility as first-line treatment of this disease,' the authors write in the paper. Patients also performed quality-of-life analyses using the EORTC QLQ-C30 questionnaire, along with the pancreatic cancer–specific PAN26 addendum, 'and using these tools, there was an improvement in deterioration of global health status, pain, and digestive problems,' said Picozzi. Most serious adverse events (SAEs), occurring in 53.6% of the TTFields arm and 48% of controls, were related to chemotherapy or the underlying disease, and were not device-related, the authors wrote. The most common SAEs, which were relatively balanced between arms, were sepsis (6.9% TTFields vs 9.5% controls), cholangitis (5.8% vs 3.7%), bile duct obstruction (5.5% vs 3.3%), and pneumonia (5.1% vs 3.3%), which is a toxicity profile expected for gemcitabine/nab-paclitaxel, Picozzi said. Most device-related AEs were mild-to-moderate skin reactions, consistent with previous trials of TTFields, and could be managed with topical steroids and calcineurin cream. In total, 23 patients (8.4%) had device-related AEs leading to TTFields discontinuation, while discontinuation of chemotherapy due to chemotherapy-related AEs occurred in 17.2% in the TTFields group and 15.8% of controls. Pros and Cons of the Device Study discussant Brian M. Wolpin, MD, a medical oncologist and director of the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute, Boston, Massachusetts, said, 'Assuming appropriate regulatory approvals, I think the combination of the survival increase and quality-of-life benefits suggests this could be an approach that we could use in patients with locally advanced pancreatic cancer.' But 'there are some lifestyle constraints of wearing the device 18 hours a day continuously for months,' he noted. Wolpin's comments also raised the question of whether TTFields could be combined with other first-line choices for LA-PAC, and pointed out that some oncologists treat locally advanced disease with chemotherapy other than gemcitabine/nab-paclitaxel. 'Many of the newer trials have now started to use multi-agent chemotherapy, many different chemotherapy programs, and different lengths of of these trials have used radiation, some have not,' he said. Indeed, the addition of radiation to first-line chemotherapy for LA-PAC is 'very, very routine' in the United States, Michael Chuong, MD, told Medscape Medical News . Nevertheless, Chuong, a professor of radiation oncology at Florida International University in Miami and medical director of radiation oncology at Miami Cancer Institute, called PANOVA-3's results exciting. 'The use of chemotherapy, plus any other non-chemo treatment, has never before shown a survival difference,' he said. 'For example, randomized trials of chemotherapy, plus or minus definitive radiation therapy, showed only differences in local control. I would say [this trial] definitely is going to lead to this becoming a standard-of-care option now. Whether all patients with locally advanced pancreatic cancer should be getting this remains to be seen.' He said the trial's ad hoc finding of statistically significant benefit for TTFields in distant PFS — but not local PFS — suggests that TTFields may be most effective at delaying metastasis. 'If it's delaying onset of liver and peritoneal disease, which almost every one of these patients will ultimately develop, that's huge,' he said, adding that the trial's high number of participants with CA 19-9 levels greater than 1000 suggested a certain amount of metastatic disease in the cohort. Other TTFields Research Is Ongoing Chuong is conducting a single-arm, phase 2 study in the same type of population. In his study, TTFields is being combined with stereotactic ablative body radiation (SABR) in the first-line setting, and he has hypothesized that this will delay metastasis. 'From a mechanistic standpoint, this is a treatment that's applied to the entirety of the abdomen. These low electrical fields are delivered to the peritoneum, into the liver, and that's where the predominant site of distant metastatic disease is in these patients.' The study was funded by Novocure GmbH. Picozzi disclosed stock and other ownership interests in Amgen, Cigna, Iovance Biotherapeutics, Johnson & Johnson, Lilly, McKesson, and Thermo Fisher; a scientific consulting or advisory role with Revolution Medicines, TriSalus Life Sciences; and research funding from AbbVie, Amal Therapeutics, Astellas Pharma, FibroGen, Ipsen, and NovoCureBrian. Wolpin disclosed a consulting or advisory role with Agenus, BeiGene, EcoR1 Capital, Harbinger Health, Ipsen, Mirati Therapeutics, Revolution Medicines, Tango Therapeutics, and Third Rock Ventures; and research funding from Amgen (Inst), AstraZeneca (Inst), Harbinger Health (Inst), Lilly (Inst), Novartis (Inst), and Revolution Medicines (Inst). Chuong disclosed funding from Novocure, Viewray, and Stratpharma.
Yahoo
3 hours ago
- Yahoo
'Wasting your time': NRL legend responds amid Nathan Cleary and Mary Fowler rumour
😃 The good: NRL greats don't think Nathan Cleary will move 😔 The bad: Benji Marshall and Wests Tigers spiralling again 😡 The ugly: Ezra Mam's on-field act during Broncos loss You're wasting your time. That's the message from four of rugby league's biggest names in response to rumours Nathan Cleary might be eyeing a switch to rugby union. Former Wallaby Tim Horan fired up the juicy bit of gossip last week, suggesting the Panthers superstar was "quite keen" to leave the NRL for the 15-man game. Another ex-Wallaby, Morgan Turinui, was happy to run with the story, adding "there is interest on both sides". If you believe the narrative, the rumours have Cleary moving to a UK/European rugby club to be closer to partner Mary Fowler. It all sounds good in theory but is it actually a chance of happening? Not according to those in the know. "What's today, June 1 - it's not April 1. I'm saying a big fat no. That won't happen," Immortal Andrew Johns told the Sunday Footy Show. Queensland Origin coach Billy Slater was another to cast doubt on the move. He said: "It would be a pull-off for the Wallabies if they could get Nathan Cleary, but I don't think that would happen. I'd be surprised if Nathan challenged himself with that." Cameron Smith and Brad Fittler also wrote off the possibility. But we learned a long time ago to never outrightly dismiss any scenario when it comes to rugby league. Watch this space. View this post on Instagram A post shared by NRL on Nine (@nrlonnine) Benji Marshall insists the Tigers have left the Lachlan Galvin drama behind them and are sick of talking about the departed five-eighth. That may be the case, but the club's results since Galvin announced he wanted out shows a worrying trend. Going back to the Easter Monday clash against Parramatta – which Galvin missed after being axed in the wake of his decision not to accept a contract extension – the Tigers have won just two games in six. From occupying a position in the top eight, Marshall's men have now slipped to 13th ahead of a testing run of games. Alarmingly, they have conceded 146 points in their past four games, which included the nightmare 64-0 defeat to Melbourne. The Tigers showed plenty of ticker to fight back against the Cowboys on Saturday night, but the fact remains they trailed 32-6 at one stage. The recent drop off cannot all be put down to Galvin's exit but there's no doubt the ongoing circus has been a major distraction. High profile recruit Jarome Luai is doing his best to keep his side in the contest but is clearly frustrated and agitated as he prepares to take on his old Panthers teammates this weekend. After three straight wooden spoons, Tigers fans are starting to wonder whether the supposed revival is fast becoming a mirage. The out-of-form Broncos have enough problems without Ezra Mam adding to their dramas. The disgraced five-eighth was hit by a barrage of abuse by Manly fans each time he touched the ball during Brisbane's awful 34-6 loss at 4 Pines Park on Saturday night. It's the first time Mam has played outside of Queensland since returning from a nine-game ban for crashing into car while unlicensed and under the influence of drugs, injuring three people. And while he was given a soft ride back into the NRL in front of his own fans in Round 11, those south of the border clearly aren't willing to forgive and forget. Mam didn't help his cause at Brookvale, jumping to his feet with arms outstretched in a Christ the Redeemer pose after scoring his side's only try. Some saw his actions as lacking humility and class given his off-field troubles, jumping on social media to condemn his actions. Sea Eagles life member and veteran media figure Peter Peters said: "I think the booing of Ezra Mam showed the NRL got it wrong in the suspension for what he did. He's got to be a little more humble. He's not everyone's cup of team at the moment. "To act like he did…to look to the heavens and poke his chest out like he's something special was hard to take. He needs to take a good look at himself."
